New Clinical Insights in Cognitive Health
Clinical Evidence on RiboDIET ® and RiboMIX SC in Mild Cognitive Impairment
Prosol will present new clinical data on RiboDIET ® and RiboMIX SC for the support of cognitive function in individuals with Mild Cognitive Impairment (MCI)—an early stage of cognitive decline where daily activities remain largely unaffected.
These two yeast-derived nucleotide-based ingredients are designed to support cognitive performance and promote healthy aging. A randomized, controlled clinical study evaluated supplementation with:
• RiboDIET ® (250 mg/day)
• RiboMIX SC (350 mg/day)
After 6 months, significant improvements in cognitive performance and mental well-being were observed.
These findings highlight the potential of RiboDIET ® and RiboMIX SC as science-backed ingredients for next- generation cognitive health formulations.
The session will be presented by Prof. Maria Daglia, Full Professor of Food Chemistry at the University of Naples Federico II and a leading expert in nutraceutical research.
Don’t miss the opportunity to explore the study results and formulation applications:
Register for the scientific session > Efficacy of RiboDIET® and RiboMIX SC in mild cognitive impairment
Schedule a meeting with our team at booth #3A256
We look forward to meeting you in Barcelona!
Prosol – Getting the best from yeast
Event Details
EVENT DETAILS
Fira de Barcelona, Spain
May 5–7, 2026
Opening hours
• May 5–6: 10:00 AM – 6:00 PM
• May 7: 10:00 AM – 4:00 PM